Expanding Demand Across Hormonal Health: Market Outlook The Europe Hormone Replacement Therapy (HRT) market continues on a ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Olema Pharmaceuticals palazestrant shows promise in late-stage trials for metastatic breast cancer with potential FDA ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Family-controlled Spanish pharma company Esteve has signed a license and supply agreement with Eton Pharmaceuticals (Nasdaq: ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech ... monthly human growth hormone (hGH ...

ESTEVE has signed a license and supply agreement with Eton Pharmaceuticals with global rights for Increlex®, except for USA.  This biologic product, the first biologic in ESTEVE's portfolio, is used ...